Launching NFX Bio and The Rise of the Scientist Founder
2 de feb. de 2021 ·
24m 31s
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Today we're announcing NFX Bio, a new fund initiative led by some of biotech's most successful Founder/CEOs. Our mission is to back seed-stage companies building bio-platforms that solve the biggest...
mostra más
Today we're announcing NFX Bio, a new fund initiative led by some of biotech's most successful Founder/CEOs. Our mission is to back seed-stage companies building bio-platforms that solve the biggest challenges facing humanity.
NFX Bio is led by Omri Amirav Drory, Ph.D., Founder/CEO of Genome Compiler (acquired by Twist Bioscience). Joining him on the Investment Committee is Emily LeProust, Ph.D., Co-Founder & CEO of Twist Bioscience (TWST - NASDAQ), as well as NFX GP's James Currier and Gigi Levy-Weiss.
By combining software/data tech with biology, and by architecting businesses with a platform approach, a whole new future of possibilities is unlocked.
Information technology has dominated human progress for forty years. And the next phase is going to be led by Scientist-Founders who build info-tech powered bio companies. The rise of the Scientist-Founder is now.
In this closed-door conversation, Omri, Emily, and James break down what they’re looking for, and what Scientists need to master in order to be CEOs.
Read the full NFX Essay here - https://www.nfx.com/post/launching-nfx-bio/
mostra menos
NFX Bio is led by Omri Amirav Drory, Ph.D., Founder/CEO of Genome Compiler (acquired by Twist Bioscience). Joining him on the Investment Committee is Emily LeProust, Ph.D., Co-Founder & CEO of Twist Bioscience (TWST - NASDAQ), as well as NFX GP's James Currier and Gigi Levy-Weiss.
By combining software/data tech with biology, and by architecting businesses with a platform approach, a whole new future of possibilities is unlocked.
Information technology has dominated human progress for forty years. And the next phase is going to be led by Scientist-Founders who build info-tech powered bio companies. The rise of the Scientist-Founder is now.
In this closed-door conversation, Omri, Emily, and James break down what they’re looking for, and what Scientists need to master in order to be CEOs.
Read the full NFX Essay here - https://www.nfx.com/post/launching-nfx-bio/
Información
| Autor | The NFX Podcast |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
